Partner Content Partner Content Career opportunities for graduates in the pharmaceutical ind... Career opportunities for graduates in healthcare
Events Partner Content J+D Forecasting bring their Face-to-Face Pharma training to ... Face-to-Face Pharma Forecasting Training in Boston
Events Partner Content Cell and Gene Therapy Manufacturing Forum Last year we told you that the cell and gene industry would be worth $9 - $14 billion by 2026. We were wrong.
Events Partner Content 13th Annual Industry Leading Cold Chain Distribution Confere... 13th Cold Chain Distribution Conference 2018
Partner Content Partner Content Pharmaceutical Microbiology USA Event takes place in less th... SMi Pharma Micro West Coast USA
News FDA resurrects Satsuma's nasal migraine treatment More than a year after it was rejected by the FDA, Satsuma Pharma's intranasal migraine therapy Atzumi has been given the go-ahead by the agency.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
